Semaglutide or Tirzepatide: GLP-1 receptor agonists work through entirely different mechanisms (appetite suppression, glucose regulation, delayed gastric emptying) compared to AOD-9604s direct lipolytic effects
Mitochondrial Oxidative Capacity AOD-9604 substantially increases whole-body fat oxidation with elevated plasma glycerol levels (an index of lipolysis)
They are not intended to represent clinical evidence in humans, and 5-Amino-1MQ has not been approved by the FDA, EMA, or any other regulatory authority for any indication
We specialize in supplying high-purity research peptides with a focus on transparency, fast domestic delivery, and dedicated customer support
If you see AOD 9604 mentioned in the news or by health influencers, remember that its primary strength lies in its ability to mimic a natural human process without the metabolic noise of traditional hormones